Showing results (261-270 of 301) with videos related to
Sort By:
Pageof 31
Oncology|January 1, 1980
An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancerJ Rubin, D A Decker, D L Ahmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1984
Clinical trial of sequential N-phosphonacetyl-L-aspartate, thymidine, and 5-fluorouracil in advanced colorectal carcinomaM J O'Connell, C G Moertel, J Rubin, et al.Investigational New Drugs|August 1, 1991
Phase II evaluation of menogaril in patients with advanced hypernephromaH J Long, M D Hauge, T M Therneau, et al.The New England Journal of Medicine|September 11, 1986
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogueL K Kvols, C G Moertel, M J O'Connell, et al.The Journal of the American Board of Family Practice|January 1, 1988
Cost-effectiveness of office obstetrical ultrasound in family practice: preliminary considerationsR G Hahn, S Ho, L D Roi, et al.American Journal of Clinical Oncology|August 1, 1983
Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinomaJ Rubin, L K Kvols, C G Moertel, et al.Alcoholism, Clinical and Experimental Research|November 7, 2001
Do ethanol and deuterium oxide distribute into the same water space in healthy volunteers?A Norberg, B Sandhagen, L E Bratteby, et al.Cancer|May 1, 1988
An evaluation of recombinant leukocyte A interferon with aspirin in patients with metastatic renal cell cancerE T Creagan, J C Buckner, R G Hahn, et al.Medical and Pediatric Oncology|January 1, 1978
A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomasE T Creagan, J H Edmonson, R G Hahn, et al.JAMA|November 9, 1979
Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysisD A Decker, D L Ahmann, H F Bisel, et al.Pageof 31